Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/REMEGEN-CO-LTD-119080101/news/RemeGen-Co-Ltd-to-Present-telitacicept-Phase-III-Clinical-Trial-Results-for-Rheumatoid-Arthritis-45364078/?utm_source=whatsapp&utm_medium=social&utm_campaign=share